3Papadokostakis G, Damilakis J, Mantzouranis E, et al. The effectiveness of calcitonin on chronic back pain and daily activities in postmenopausal women with osteoporosis. European Spine Journal, 2005,29(9) : 150-154.
4Miroslava H, Vladimir P, Zdenek K, et al. Effects of alendronate and calcitonin on bone mineral density in postmenopausalosteoporotic women:an observational study. Pharm World Sci, 2005, 27 : 149-153.
5Beaudreuil J, Taboulet J, Orcel P, et al. Calcitonin receptor mRNA in mononuclear leucocytes from postmenopausal women:decrease during osteoporesis and link to bone markers with specific isoform involvement.Bone ,2003,27( 1 ) :161 - 168.
6Davey RA, Morris HA. The effects of salmon calcitonin - induced hypocalcemia on bone metabolism in ovariectomized rats. J Bone Miner Metab, 2005,23:359-365.
7Birgit S, Christopher R, Emmanuel P, et al. Long - term doxycycline -regulated secretion of erythropoietin by encapsulated myoblasts. Molecular Therapy, 2002, 6(2):155 - 156.
8Francesca P, Delphine L, Elena Z, et al . Analysis of differential lipofection efficiency in primary and established myoblasts. Molecular Therapy,2002, 5(2) :161-163.
9Gauer F,Poirel VJ,Garidou ML,et al.Molecular cloning of the arylalkylamine-N-acetytransferase and daily variations of its mRNA expression in the Syrian hamster pineal gland[J].Molecular Brain Research,1999,71 (1):87-95.
10Uludag H,De Vos P,Tresco PA.Technology of mammalian cell encapsulation[J].Adv Drug Deliv Rev,2000,20,42(1-2):29-64.
